Treatment with the pan-HDACs inhibitors sodium butyrate or the class I HDAC inhibitor MS-275 improves insulin sensitivity in mice with diet-induced obesity [46] and obese db/db mice [47], respectively. This evidence concerns the gene HDAC9 and obesity due to melanocortin 4 receptor deficiency.